In TNBC, METTL3 is an important collaborator in regulating metastasis, and low expression of METTL3 is implicated in the poor prognosis of triple-negative breast cancer (TNBC) (Shi et al., 2020). Here, METTL3 is linked to triple-negative breast carcinoma.